A. Sidney Barritt Athens Cancer Chapel Hill Chulalongkorn University Chulalongkorn University, Bangkok Connecticut Diabetes Emory University Ernest N. Morial Frank Anania Greek Organisation Against Drugs HCV HCV RNA HCV treatment Hall F Hepatitis C Liver Fibrosis Liver transplant MRI Marie B. Gale Mayo Clinic New Orleans North Carolina Obesity Olga Anagnostou Rochester Roger D. Soloway Sombat Treeprasertsuk Texas Thailand Thessaloniki Transplantation United States University of North Carolina University of Texas Medical Branch chronic chronic HCV infection cirrhosis disease epidemic epidemics fatty liver gastrointestinal surgery health heart disease hepatocellular carcinoma high blood pressure high cholesterol liver disease liver transplants ultrasound
Researchers make advances in understanding causes, treatments and outcomes of liver disease
NEW ORLEANS, LA (May 2, 2010) -- Non-alcoholic fatty liver disease (NAFLD), which may soon be the leading indication for liver transplant, is found to be significantly associated with worse transplant outcomes.
Read the full article at ScienceBlog.com - diabetes
